White, Harvey D <br/><br/>
Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.  [electronic resource] 

 -  Journal of the American College of Cardiology  May 2008 
 - 1734-41 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1558-3597 
<br/><br/><label>Standard No.: </label>10.1016/j.jacc.2007.12.052  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--drug therapy<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anticoagulants--adverse effects<br/>Enoxaparin--adverse effects<br/>Female<br/>Heart Conduction System--physiopathology<br/>Heparin--adverse effects<br/>Hirudins--adverse effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Myocardial Ischemia<br/>Peptide Fragments--adverse effects<br/>Platelet Glycoprotein GPIIb-IIIa Complex--drug effects<br/>Recombinant Proteins--adverse effects<br/>Risk Factors<br/>Treatment Outcome